Joincare Pharmaceutical Group Industry Co.,Ltd. (600380.SS) has a MoatMap StockRank of 93/100 based on Quality (71/100), Value (72/100), and Momentum (38/100) factor scores. The current signal is STRONG BUY. While Joincare exhibits decent quantitative metrics, it operates primarily as a traditional pharmaceutical and chemical manufacturer in China, lacking the specialized, high-moat CDMO capabilities or global pricing power required to capitalize on the CDMO Pricing Power Cycle.
Joincare Pharmaceutical Group Industry Co., Ltd. researches, manufactures, and distributes chemical drugs, active pharmaceutical ingredients (APIs), and traditional Chinese medicines. The company has established a strong market position in high-barrier inhalation formulations and complex generic drugs, supported by robust R&D. It is a highly diversified pharmaceutical group with a strong focus on respiratory treatments.
| Price | $1.45 |
| Market Cap | $2.8B |
| P/E (TTM) | 13.51 |
| P/E (Forward) | 11.08 |
| Price/Book | 1.13 |
| Return on Equity | 11.5% |
| Return on Invested Capital | 13.0% |
| Debt/Equity | 15.92 |
| Gross Margin | 62.5% |
| Operating Margin | 26.3% |
| Revenue Growth | -9.0% |
| Dividend Yield | 2.0% |
| Free Cash Flow | $54M |
Joincare Pharmaceutical Group Industry Co.,Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).